NP0332346 | compound 10 in CD3CN | | | C12H18O3
210.2730 Da 210.12559 Da | 1H NMR Spectrum (1D, 600.15348087, CD3CN, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) |
|
NP0332347 | compound 6 in CD3OD | | | C12H14O4
222.2400 Da 222.08921 Da | 1H NMR Spectrum (1D, 400.133121014, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332348 | compound 8 in CD3CN | | | C12H18O3
210.2730 Da 210.12559 Da | 1H NMR Spectrum (1D, 400.133121014, CD3CN, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332349 | Prugosene A3-compound 3 in CD3OD | | | C28H36O5
452.5910 Da 452.25627 Da | 1H NMR Spectrum (1D, 400.133121014, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332350 | compound 5 in CDCl3 | | | C28H38O5
454.6070 Da 454.27192 Da | 1H NMR Spectrum (1D, 400.133121014, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332351 | compound 4 in CD3OD | | | C28H38O5
454.6070 Da 454.27192 Da | 1H NMR Spectrum (1D, 400.133121014, CD3OD, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332352 | compound 9 in CD3CN | | | C12H18O3
210.2730 Da 210.12559 Da | 1H NMR Spectrum (1D, 400.133121014, CD3CN, simulated) | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332353 | Taxifolin | | | C15H12O7
304.2516 Da 304.05830 Da | 1H NMR Spectrum (1D, 600.133705802, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332354 | Equol | | | C15H14O3
242.2699 Da 242.09429 Da | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332355 | 5-alpha-cholestanol | | | C27H48O
388.6694 Da 388.37052 Da | |
NP0332356 | Sinucycloamtin D | | | C20H28O2
300.4420 Da 300.20893 Da | 1H NMR Spectrum (1D, 599.6337058, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) |
|
NP0332357 | Sinulobatin C | | | C22H32O3
344.4950 Da 344.23514 Da | 1H NMR Spectrum (1D, 400.13280091, CDCl3, simulated) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) |
|
NP0332358 | Sinulobatin D | | | C24H34O4
386.5320 Da 386.24571 Da | |
NP0332359 | Sinucycloamtin A | | | C24H32O4
384.5160 Da 384.23006 Da | 1H NMR Spectrum (1D, 600.0360003, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) |
|
NP0332360 | Sinucycloamtin C | | | C22H30O3
342.4790 Da 342.21949 Da | 1H NMR Spectrum (1D, 500.133088507, CDCl3, simulated) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) |
|
NP0332361 | Sinucycloamtin B | | | C22H30O3
342.4790 Da 342.21949 Da | 1H NMR Spectrum (1D, 500.133088507, CDCl3, simulated) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) |
|
NP0332362 | Prugosene A2 | | | C28H36O5
452.5910 Da 452.25627 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332363 | (2E,4E,6E)-7-((1R,6R,7S)-4,6,7-trimethyl-3,5-dioxo-2-oxabicyclo[2.2.1]heptan-7-yl)hepta-2,4,6-trienal | | | C16H18O4
274.3160 Da 274.12051 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332364 | Prugosene A1 | | | C28H36O5
452.5910 Da 452.25627 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332365 | (E)-3-((2R,3R,6S)-3-hydroxy-3,5,6-trimethyl-3,6-dihydro-2H-pyran-2-yl)but-2-enal | | | C12H18O3
210.2730 Da 210.12559 Da | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) |
|
NP0332366 | (E)-3-((1R,6R,7S)-4,6,7-trimethyl-3,5-dioxo-2-oxabicyclo[2.2.1]heptan-7-yl)acrylaldehyde | | | C12H14O4
222.2400 Da 222.08921 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332367 | (E)-3-((2S,5S,6S)-5-hydroxy-3,5,6-trimethyl-5,6-dihydro-2H-pyran-2-yl)but-2-enal | | | C12H18O3
210.2730 Da 210.12559 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332368 | Prugosene A3 | | | C28H36O5
452.5910 Da 452.25627 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332369 | (1R,5S,6S,7S)-5-hydroxy-7-((1E,3E,5E,7E,9E)-10-((2R,5S,6S)-5-hydroxy-3,5,6-trimethyl-5,6-dihydro-2H-pyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl)-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptan-3-one | | | C28H38O5
454.6070 Da 454.27192 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0332370 | (1R,5R,6S,7S)-5-hydroxy-7-((1E,3E,5E,7E,9E)-10-((2R,5S,6S)-5-hydroxy-3,5,6-trimethyl-5,6-dihydro-2H-pyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl)-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptan-3-one | | | C28H38O5
454.6070 Da 454.27192 Da | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|